Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Anticancer Research|December 1, 2022
Bendamustine Plus Rituximab for Mantle Cell Lymphoma: A Korean, Multicenter Retrospective AnalysisJun Ho Yi, Seok Jin Kim, Jeong-Ok Lee, et al.
Scientific Reports|December 24, 2014
Anti-tumor efficacy of fulvestrant in estrogen receptor positive gastric cancerJun Ho Yi, In-Gu Do, Jiryeon Jang, et al.
Anticancer Research|October 15, 2013
Effects of single nucleotide polymorphisms on treatment outcomes and toxicity in patients treated with sunitinibChi Hoon Maeng, Jun Ho Yi, Jeeyun Lee, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 11, 2010
Clinical presentation of carcinoma of unknown primary: 14 years of experienceJun Ho Yi, Yoon La Choi, Su Jin Lee, et al.
Cancer Research and Treatment|August 4, 2011
Implications of bone-only metastases in breast cancer: favorable preference with excellent outcomes of hormone receptor positive breast cancerSu Jin Lee, Silvia Park, Hee Kyung Ahn, et al.
Cancer Research and Treatment|July 31, 2025
Real-World Efficacy and Safety of Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma: Nationwide Retrospective Analysis of the Named Patient Program in KoreaJun Ho Yi, Jae Hoon Lee, Sung-Hoon Jung, et al.
Blood Research|November 30, 2023
A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO studySeok Jin Kim, Young Rok Do, Ho-Sup Lee, et al.
Annals of Hematology|December 25, 2012
Genome-wide single-nucleotide polymorphism array-based karyotyping in myelodysplastic syndrome and chronic myelomonocytic leukemia and its impact on treatment outcomes following decitabine treatmentJun Ho Yi, Jungwon Huh, Hee-Jin Kim, et al.
Oncotarget|December 13, 2017
MerTK is a novel therapeutic target in gastric cancerJun Ho Yi, Jiryeon Jang, Jeonghee Cho, et al.
Investigational New Drugs|November 20, 2015
Anti-tumoral effect of arsenic compound, sodium metaarsenite (KML001), in non-Hodgkin's lymphoma: an in vitro and in vivo studyJin Sun Yoon, Deok Won Hwang, Eun Shil Kim, et al.
Pageof 7